Lab Reference Ranges for Athletes and Metabolic Markers

Lab reference ranges can misread athletes in both directions, flagging training adaptations as problems while overlooking deficiencies that limit performance. Reading metabolic and other blood markers accurately therefore takes more than checking whether a result is “normal.” A useful comparison takes account of the athlete’s training context, related markers, and own history.

Why standard lab reference ranges are not built for athletes

A reference range describes a population. To build one, a laboratory measures a marker in a reference group, with a minimum of around 120 people, though some groups include hundreds to thousands. A common method sets the interval at the mean ± 2 standard deviations, covering the great majority of those tested. That tells the reader what is common in the group. It does not establish what supports demanding training.

A general population does not necessarily represent healthy, trained physiology, and age-banded ranges may accept lower testosterone values in older men. Assays, instruments, and local populations also differ between laboratories, so a result can fall inside one facility’s range and outside another’s. The measurement need not be wrong for the interpretation to fail. Athletes face both false positives, when adaptations look abnormal, and false negatives, when performance-limiting deficiencies look normal.

How trained physiology diverges from the reference population at baseline

Plasma volume expands, diluting red blood cell concentration and lowering measured hemoglobin and hematocrit. The concentration is not the whole story. An athlete with apparently low hemoglobin may have normal or elevated total hemoglobin mass, distributed through more plasma. This expansion reverses after training stops, supporting its interpretation as a training-specific adaptation.

Other systems also operate at different set-points. Frequent training can produce chronically elevated resting creatine kinase, while energy deficit can suppress free T3 even when TSH remains normal. But these changes do not all mean the same thing. Plasma expansion may be beneficial, whereas a hormonal response to inadequate energy can impair recovery. The sedentary baseline is therefore an incomplete comparator, and abnormal results still require evaluation.

Ferritin: the marker where the standard range most consequentially fails endurance athletes

Iron stores can become inadequate for endurance demands before anemia appears. A result may remain within the laboratory range while the athlete’s stores are low enough to limit performance. Iron demand is structurally higher in this setting. Foot-strike haemolysis mechanically destroys red blood cells, sweat adds iron losses, and inflammation-triggered hepcidin release after hard training suppresses absorption for several hours. Altitude training and periods of intensive training also speed up red blood cell turnover.

Ferritin is an acute-phase reactant, so inflammation or recent illness can raise it and make depleted stores look more reassuring than they are. Transferrin saturation and hs-CRP help distinguish these possibilities. What looks like an adequate reserve may partly reflect inflammation. That is why a ferritin result cannot be read accurately without the surrounding markers and training history.

The treatment evidence also requires care. Studies of iron supplementation in non-anemic athletes found performance benefits in roughly half and no benefit in roughly half, with benefits more likely in studies using the lowest ferritin cutoff of ≤20 µg/L. Preventing further decline is a different goal from assuming supplementation will improve performance. Too much iron without a confirmed deficiency has no benefit and can cause harm, so a single result is a poor basis for self-treatment.

Creatine kinase and the false-positive trap: when "abnormal" is just training

Standard clinical ranges for creatine kinase, or CK, commonly go up to around 200 U/L for women and 310–320 U/L for men, but trained athletes can often be above those limits even at rest. Intensive exercise adds an acute rise that falls back within a few days. A flag after training can reflect either normal muscle adaptation or a problem that needs treatment. The cutoff alone cannot make that distinction.

Persistently elevated CK when recovery is inadequate can signal genuine overloading, and an already high resting value can obscure that change. The athlete’s own earlier baseline helps with this comparison. A number that looks alarming may be normal for that athlete, while one within the population range may be much higher than it was before. LDH, which marks cell damage and also rises with training load, needs the same context-first interpretation.

Thyroid markers in athletes: why TSH alone misses the signal

TSH is a reasonable starting point for thyroid screening, but it can miss the response to inadequate energy availability. Under energy stress, the hypothalamic-pituitary axis can suppress free T3 production before TSH shifts outside its range. The screen can look reassuring too early. Free T3 is the metabolically active thyroid hormone, and when it falls, it can impair fat oxidation, slow muscle recovery, and lower resting metabolic rate. Even a result near the lower edge of its range may warrant attention in context.

This raises a different question from whether a cutoff is appropriate. Has the panel measured enough of the system to explain what is happening? Standard TSH ranges go up to 4.0 mIU/L, but reading an athlete’s result also means taking account of symptoms, energy availability, and free T3. A normal TSH does not establish that energy metabolism is unaffected by under-fuelling. Choosing the right marker is therefore as important as choosing the right comparator, without implying that an isolated low result establishes a need for thyroid treatment.

Vitamin D, testosterone, and the cortisol-to-testosterone ratio: markers where functional targets diverge from statistical norms

Vitamin D shows how preventing disease caused by deficiency differs from meeting the demands of training. Standard sufficiency thresholds address the former, while sports medicine contexts may use higher targets for bone health and power output. These are different questions about the same marker. A result that clears a deficiency threshold does not automatically settle whether it is sufficient for athletic demands. Functional targets still need to fit the athlete’s circumstances.

Testosterone has an additional interpretive complication in men. Total testosterone may sit within range while free testosterone, the fraction available to enter muscle cells, is functionally low because sex hormone-binding globulin, or SHBG, is elevated. The total can conceal the available fraction. Low-normal total testosterone can also go along with poor recovery and mood even when no clinical deficiency has been diagnosed. Free testosterone and SHBG provide information that a total-only panel leaves out.

The cortisol-to-testosterone ratio reflects the balance between catabolic and anabolic processes, and it can rise during overtraining as testosterone drops while cortisol remains elevated. Fixed cutoffs are inconsistent across the literature. Tracking the ratio over time at the same laboratory is therefore more informative than treating one value as decisive. Morning cortisol also provides a training-stress signal, but its trend across the training cycle is more useful than a single draw.

Metabolic and cardiovascular markers athletes routinely underweight

Being fit can lead athletes to overlook some cardiovascular risks. A routine lipid panel reports total cholesterol, LDL-C, HDL, and triglycerides, but those measurements do not answer every risk question. ApoB can add information when the markers disagree and can better reflect atherosclerotic cardiovascular disease risk than cholesterol fractions alone. It belongs alongside the routine lipid panel for a more complete assessment.

Lipoprotein(a), or Lp(a), fills a different gap. It is predominantly determined by genetics and remains stable through life, so most adults need it measured only once. A 2025 JACC study found that LDL-C, non-HDL-C, ApoB, and hsCRP explained little of the cardiovascular risk associated with Lp(a). Even an expanded lipid assessment can leave this inherited signal unmeasured.

An hs-CRP value above 2.0 mg/L can be a sign of vascular inflammation, but heavy training also raises hs-CRP, so a high result after exercise cannot be assumed to have a cardiovascular cause. Timing helps distinguish the competing interpretations. Fasting insulin, measured after at least eight hours without food, can be a sign of insulin resistance before glucose or HbA1c changes. Athletes with high training volumes and high-carbohydrate diets can still have normal glucose with elevated fasting insulin, which standard metabolic panels do not include.

Why a single value against a population cutoff answers the wrong question

A laboratory flag asks whether a value fits a reference population. The athlete needs to know whether physiology is changing in a way that affects health, recovery, or performance. Those questions overlap, but they are not interchangeable. Iron status interacts with inflammation, endocrine function responds to energy availability, and training load influences several markers at once.

A ferritin of 22 ng/mL, for example, means something different when hs-CRP is elevated because inflammation may be lifting ferritin above the level that stores alone would produce. Testosterone becomes more interpretable when SHBG and cortisol are also known. History adds another dimension to both examples. Ferritin that has fallen steadily across three panels tells a different story from a result that has stayed at the same number. Likewise, CK that has doubled from an athlete’s baseline deserves attention even if it remains within the population interval.

That personal baseline is not permission to ignore population limits. Reference ranges remain a coarse safety net for detecting overt pathology, while serial results help reveal changes they were not designed to detect. Timing must also be part of the comparison. CK and hs-CRP reflect recent training, cortisol varies through the day, and illness can alter ferritin. With those relationships understood, a standard report becomes a tool for identifying useful questions.

How athletes can build a testing practice that produces interpretable results

Make each draw comparable with the last. Blood should be collected fasted, in the morning, and with sufficient time after the last intensive session. Acute training load can distort CK, white blood cell count, hs-CRP, and ferritin, making a post-session draw unreliable as a resting baseline. A pre-season draw provides an anchor. Testing six to eight weeks before the main training phase gives a result when the athlete is fairly rested, and mid-season results can then show how much has changed from that baseline.

The marker set should follow symptoms, training context, and earlier findings. Useful extensions to a standard CBC and metabolic panel include ferritin with transferrin saturation and hs-CRP, and free T3 with TSH. Free testosterone and SHBG can add to what total testosterone shows, while morning cortisol and vitamin D (25-OH) help answer other questions about recovery. ApoB, a once-only Lp(a) measurement for most adults, and fasting insulin can fill metabolic and cardiovascular gaps. More testing is not automatically more useful.

For longitudinal tracking, using the same laboratory reduces noise from different assays and reference populations. Using the same laboratory leaves some sources of variation in place, but makes changes easier to understand. Clinician review supplies the remaining link to a decision. A standard report cannot automatically account for an athlete’s training physiology, symptoms, or energy availability. A practitioner who understands those relationships can judge whether a change comes from adaptation, too little recovery, or something that needs more attention.